Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frazer A Tessema

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Health Affairs (Project Hope)|May 3, 2021
Diabetes Drugs: List Price Increases Were Not Always Reflected In Net Price; Impact Of Brand Competition UnclearAmeet Sarpatwari, Frazer A Tessema, Marie Zakarian, et al.
Drug Safety|November 18, 2020
Changes in Erythropoiesis Stimulating Agent Use Under a Risk Evaluation and Mitigation Strategy (REMS) ProgramAmeet Sarpatwari, Mengdong He, Frazer A Tessema, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|January 6, 2021
Generic Competition for Drugs Treating Rare DiseasesReed F Beall, Amity E Quinn, Aaron S Kesselheim, et al.
Journal of Managed Care & Specialty Pharmacy|October 31, 2019
Physician Perceptions of Step Therapy Prescribing RequirementsMichael A Fischer, Aaron S Kesselheim, Zhigang Lu, et al.
JAMA Internal Medicine|January 23, 2019
Physicians' Perspectives on FDA Approval Standards and Off-label Drug MarketingAaron S Kesselheim, Steven Woloshin, Zhigang Lu, et al.
Journal of General Internal Medicine|October 7, 2018
Internal Medicine Physicians' Financial Relationships with Industry: An Updated National EstimateAaron S Kesselheim, Steven Woloshin, Zhigang Lu, et al.
Circulation. Cardiovascular Quality and Outcomes|November 12, 2019
Randomized Study of Providing Evidence Context to Mitigate Physician Misinterpretation Arising From Off-Label Drug PromotionLisa M Schwartz, Steven Woloshin, Zhigang Lu, et al.
JACC. Case Reports|June 19, 2026
Eisenmenger Syndrome Complicated by Hemorrhagic Hereditary Telangiectasia: Unique Intersection of Hemorrhage, Cyanosis, and ThrombosisFrazer A Tessema, Madhusudan Ganigara, Orly Leiva, et al.
Trauma Surgery & Acute Care Open|June 20, 2022
Sickle cell trait and multisystem trauma: an unaddressed urgent knowledge gapFrazer A Tessema, Gabrielle Lapping-Carr, Murtala I Affini, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|July 11, 2023
High Cost of Chimeric Antigen Receptor T-Cells: Challenges and SolutionsEdward R Scheffer Cliff, Amar H Kelkar, David A Russler-Germain, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Health Affairs (Project Hope)|May 3, 2021
Diabetes Drugs: List Price Increases Were Not Always Reflected In Net Price; Impact Of Brand Competition UnclearAmeet Sarpatwari, Frazer A Tessema, Marie Zakarian, et al.
Drug Safety|November 18, 2020
Changes in Erythropoiesis Stimulating Agent Use Under a Risk Evaluation and Mitigation Strategy (REMS) ProgramAmeet Sarpatwari, Mengdong He, Frazer A Tessema, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|January 6, 2021
Generic Competition for Drugs Treating Rare DiseasesReed F Beall, Amity E Quinn, Aaron S Kesselheim, et al.
Journal of Managed Care & Specialty Pharmacy|October 31, 2019
Physician Perceptions of Step Therapy Prescribing RequirementsMichael A Fischer, Aaron S Kesselheim, Zhigang Lu, et al.
JAMA Internal Medicine|January 23, 2019
Physicians' Perspectives on FDA Approval Standards and Off-label Drug MarketingAaron S Kesselheim, Steven Woloshin, Zhigang Lu, et al.
Journal of General Internal Medicine|October 7, 2018
Internal Medicine Physicians' Financial Relationships with Industry: An Updated National EstimateAaron S Kesselheim, Steven Woloshin, Zhigang Lu, et al.
Circulation. Cardiovascular Quality and Outcomes|November 12, 2019
Randomized Study of Providing Evidence Context to Mitigate Physician Misinterpretation Arising From Off-Label Drug PromotionLisa M Schwartz, Steven Woloshin, Zhigang Lu, et al.
JACC. Case Reports|June 19, 2026
Eisenmenger Syndrome Complicated by Hemorrhagic Hereditary Telangiectasia: Unique Intersection of Hemorrhage, Cyanosis, and ThrombosisFrazer A Tessema, Madhusudan Ganigara, Orly Leiva, et al.
Trauma Surgery & Acute Care Open|June 20, 2022
Sickle cell trait and multisystem trauma: an unaddressed urgent knowledge gapFrazer A Tessema, Gabrielle Lapping-Carr, Murtala I Affini, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|July 11, 2023
High Cost of Chimeric Antigen Receptor T-Cells: Challenges and SolutionsEdward R Scheffer Cliff, Amar H Kelkar, David A Russler-Germain, et al.
Pageof 3